)
Visual22 Oct 2025
Epiroc's cash spent on M&A
McKesson (MCK) investor relations material
McKesson Investor Day 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor Day 2025 summary23 Sep, 2025
Strategic priorities and business evolution
Four key growth pillars: people/culture, oncology/multispecialty, biopharma services, and North American pharmaceutical distribution, with a focus on modernizing and accelerating the portfolio.
Modernization initiatives include technology upgrades, automation, digital transformation, and AI to enhance operational efficiency and customer experience.
New organizational structure enhances alignment to strategy, with three core segments: North American Pharmaceutical, Oncology & Multi-Specialty, and Prescription Technology Solutions.
Ongoing separation of the Medical-Surgical Solutions business via IPO and spin-off, targeting completion by the second half of 2027 as a tax-free public separation while maintaining dividend levels and credit ratings.
Strategic acquisitions have expanded capabilities in clinical trials, prescription technology, and specialty care, reinforcing leadership in key growth areas.
Financial performance and guidance
Fiscal 2026 guidance raised: adjusted operating profit growth of 10%-14% and adjusted EPS growth of 15%-17% over the prior year, with FY26 adjusted EPS guidance at $38.05–$38.55.
Oncology & Multi-Specialty segment expects 27%-31% revenue growth and 49%-53% adjusted operating profit growth, driven by organic volumes and recent acquisitions.
Prescription Technology Solutions segment guidance increased to 9%-13% revenue growth and 11%-15% adjusted operating profit growth, reflecting strong demand for access and affordability solutions.
Long-term adjusted EPS growth target updated to 13%-16%, with Oncology & Multi-Specialty expected to deliver 13%-16% adjusted operating profit growth, North American Pharmaceutical 5%-8%, and Prescription Technology Solutions 10%-13%.
Free cash flow expected at $4.4–$4.8 billion in FY26, with robust balance sheet and leverage targeted at ~1.3x.
Business segment highlights and growth drivers
Leading position in North American pharmaceutical distribution, with 1/3 of pharmaceuticals distributed in the region and >99% inventory service level, leveraging scale, automation, and strategic partnerships.
Specialty pharmaceuticals, especially oncology, are key growth engines, with specialty distribution revenues reaching $90 billion in fiscal 2025 and 18% CAGR since 2021.
Oncology & Multi-Specialty platform expanded through acquisitions and joint ventures, supporting 3,300+ providers and 2.4 million annual patient visits.
Biopharma services platform addresses access, affordability, and adherence, enabling over 100 million patient medication accesses and $10 billion in annual out-of-pocket savings.
Canadian operations exhibit strong growth, with a leading independent pharmacy network and expanded specialty health solutions.
Medical-Surgical separation capital allocation impact?
What drives the 49-53% FY26 Oncology AOP growth?
Biopharma: How to shift AOP mix to higher-margin services?
MedSurg separation: capital redeployment strategy?
Multi-specialty expansion: criteria for new areas?
Drug pricing policy impact on GPO/MSO margins?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next McKesson earnings date
Q2 20265 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Global Healthcare Solutions
McKesson Corporation is a healthcare company, providing a wide range of services and solutions in the United States and internationally. The company operates through several segments, including U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. McKesson also offers technological, clinical support, and business solutions to specialty practices. McKesson Corporation is headquartered in Irving, Texas, and its shares are listed on the New York Stock Exchange.
Roots in the 1800s
The company has a history that stretches back to 1833 in NYC when it was founded as an importer and wholesaler of drugs and chemicals. Today, McKesson is one of the largest healthcare companies in the world, playing a critical role in pharmaceutical distribution and healthcare technology. The company is heavily involved in the distribution of pharmaceuticals and medical supplies, healthcare technology, and providing network infrastructure for the healthcare industry. Some similar companies traded on the public markets are Cardinal Health and Henry Schein.
The Business Segments
The company has diversified its operations into several business segments, each catering to different facets of the healthcare industry.
U.S. Pharmaceutical and Specialty Solutions: This is the largest segment of McKesson’s operations. It distributes pharmaceuticals and other healthcare-related products to a variety of customers, including retail pharmacies, hospitals, health systems, and physician offices. The segment is crucial for the supply of branded, generic, and over-the-counter pharmaceuticals. It also offers specialized solutions for oncology and other complex therapeutic areas, along with services like inventory management, technology solutions, and business support.
European Pharmaceutical Solutions: McKesson has a significant presence in Europe through its subsidiary McKesson Europe, where it operates a network of pharmacies, not just in the wholesale and distribution of pharmaceuticals, but also in direct-to-consumer retail operations. This segment includes the distribution of drugs, and healthcare products, and the operation of retail pharmacies in several European countries.
Medical-Surgical Solutions: This segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including acute care hospitals, ambulatory surgery centers, community health centers, and office-based healthcare practitioners. The focus is on delivering a comprehensive range of products and services that are essential for the day-to-day operations of healthcare facilities, ensuring they have the necessary medical supplies and equipment.
Prescription Technology Solutions: This newer segment focuses on developing and providing software, analytics, and network solutions to pharmacies, healthcare providers, and payers. The aim is to optimize the healthcare supply chain, improve patient adherence to medications, and support pharmacy operations.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage